The Role of the Microbiome in Connective-Tissue-Associated Interstitial Lung Disease and Pulmonary Vasculitis
The microbiome can trigger and maintain immune-mediated diseases and is associated with the severity and prognosis of idiopathic pulmonary fibrosis, which is the prototype of interstitial lung diseases (ILDs). The latter can be a major cause of morbidity and mortality in patients with connective-tis...
Main Authors: | Fotios Drakopanagiotakis, Elisavet Stavropoulou, Christina Tsigalou, Evangelia Nena, Paschalis Steiropoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/12/3195 |
Similar Items
-
Efficacy and Safety of Nintedanib in Patients with Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD): A Real-World Single Center Experience
by: Maria Boutel, et al.
Published: (2023-03-01) -
The diagnostic trajectories of Danish patients with autoimmune rheumatologic disease associated interstitial lung disease: an interview-based study
by: MB Johansen, et al.
Published: (2023-01-01) -
Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers
by: Fotios Drakopanagiotakis, et al.
Published: (2023-06-01) -
Expert Opinion Guidance on the Detection of Early Connective Tissue Diseases in Interstitial Lung Disease
by: Namas R, et al.
Published: (2023-05-01) -
Diagnosing interstitial lung disease by multidisciplinary discussion: A review
by: Laura M. Glenn, et al.
Published: (2022-09-01)